Studieoverzicht

 
 
 
  2017-02 PERIDENO       Closed       Adjuvant       HER2-, any HR       Postmenopausal  
  2014-05 INFLAME       Closed       Data registration       Not applicable       Not applicable  
  2014-01 MONALEESA-2       Closed       Advanced/metastatic       HER2- HR+       Postmenopausal  
  2013-07 mastectomie       Closed       Locoregional       Not applicable       Not applicable  
  2013-06 Biomarker Study Everolimus       Closed       Advanced/metastatic       HER2- HR+       Postmenopausal  
  2013-03 PERNETTA       Closed       Advanced/metastatic       HER2+, any HR       Both pre- and postmenopausal  
  2012-01 BALLET       Closed       Advanced/metastatic       HER2- HR+       Postmenopausal  
  2010-05 SUBMIT       Closed       Advanced/metastatic       Any HER2, any HR       Both pre- and postmenopausal  
  2010-03 RAPCHEM       Closed       Locoregional       Not applicable       Not applicable  
  2010-02 STOP&GO       Closed       Advanced/metastatic       HER2-, any HR       Both pre- and postmenopausal  
  2010-01 NEO-ZOTAC       Closed       Neoadjuvant       HER2-, any HR       Both pre- and postmenopausal  
  2009-05 BOLERO 2       Closed       Advanced/metastatic       HER2- HR+       Postmenopausal  
  2009-04 Male BC retrospectief       Closed       Data registration       Not applicable       Not applicable  
  2009-02 SNARB       Closed       Locoregional       Not applicable       Not applicable  
  2008-03 HAT       Closed       Advanced/metastatic       HER2+, any HR       Both pre- and postmenopausal  
  2008-02 A6181099       Closed       Advanced/metastatic       Any HER2, any HR       Both pre- and postmenopausal  
  2008-01 2-2-6 G-CSF       Closed       Adjuvant       Any HER2, any HR       Both pre- and postmenopausal  
  2007-02 INTENS       Closed       Neoadjuvant       Any HER2, any HR       Both pre- and postmenopausal  
  2007-01 ALTTO       Closed       Adjuvant       HER2+, any HR       Both pre- and postmenopausal  
  2006-07 MIRROR       Closed       Not applicable       Not applicable       Not applicable  
  2006-06 ATX       Closed       Advanced/metastatic       HER2-, any HR       Both pre- and postmenopausal  
  2006-04a TEAM IIa       Closed       Neoadjuvant       Any HER2, HR+       Postmenopausal  
  2006-02 OMEGA       Closed       Advanced/metastatic       Any HER2, any HR       Postmenopausal  
  2006-01 DATA       Closed       Adjuvant       Any HER2, HR+       Postmenopausal  
  2004-02 TBP       Closed       Advanced/metastatic       HER2+, any HR       Both pre- and postmenopausal  
  2003-02 Calor       Closed       Adjuvant       Any HER2, any HR       Both pre- and postmenopausal  
  2002-04 HERA       Closed       Adjuvant       HER2+, any HR       Both pre- and postmenopausal  
  2002-02 Hertax       Closed       Advanced/metastatic       HER2+, any HR       Both pre- and postmenopausal  
  2001-02 AMAROS       Closed       Locoregional       Not applicable       Not applicable  
  2001-01 TEAM       Closed       Adjuvant       Any HER2, HR+       Postmenopausal